Showing 5281-5290 of 23226 results for "".
Conductive Keratoplasty and Other Techniques For Presbyopia
https://reachmd.com/programs/clinicians-roundtable/conductive-keratoplasty-other-techniques-for-presbyopia/2511/For many of us, one of the first signs of aging is presbyopia. In fact, the word comes from the Greek presbys which means old person. Other than growing longer arms or keeping a pair of reading glasses in every room, are there other treatments available? Host Dr. Leslie Lundt welcomes refractive surTrending Toward Electronic Prescriptions of Controlled Substances
https://reachmd.com/programs/clinicians-roundtable/trending-toward-electronic-prescriptions-of-controlled-substances/2411/Right now, it’s illegal to use an electronic system to prescribe controlled substances. But as the adoption of electronic prescriptions progresses, the inclusion of controlled substances into e-prescribing becomes inevitable. David Miller, chief security officer for Covisint, a leading software andBook Club: Drug Metabolism in Psychiatry
https://reachmd.com/programs/clinicians-roundtable/book-club-drug-metabolism-in-psychiatry/2401/Dr. Claudia Baldassano of University of Penn has said that today’s guest “is a master at making tedious concepts come to life”. For many of us, nothing in medicine is as tedious as drug metabolism. Dr. Daniel Carlat tells host Dr. Leslie Lundt about his latest book, “Drug Metabolism in PsychiatryThe Ethics of Using Claims Data to Profile Physicians
https://reachmd.com/programs/clinicians-roundtable/the-ethics-of-using-claims-data-to-profile-physicians/2362/Many physicians are outraged and the thought of being ranked by insurance companies altogether, let alone via an analysis of claims data. Can claims data accurately provide a picture of the quality of a physician? What part of the story does claims data fail to show? Can a physician benefit from ranThe Future of Surgery
https://reachmd.com/programs/clinicians-roundtable/the-future-of-surgery/2225/In this segment, Executive Director of the American College of Surgeons, Dr. Thomas Russell joins host Dr. Mark Nolan Hill for an insightful discussion about how the practice of surgery will change in the years to come. They discuss the increase in less invasive procedures, changing technology, incProject HOPE: 50 Years of Global Health Service
https://reachmd.com/programs/clinicians-roundtable/project-hope-50-years-of-global-health-service/2032/Dr. Maurice Pickard speaks with Dr. John Howe, president and CEO of Project HOPE, about Project HOPE's work with the U.S. Navy, from the tsunami devastation in Indonesian to the crisis in New Orleans.Identifying Hepatitis C
https://reachmd.com/programs/clinicians-roundtable/identifying-hepatitis-c/1945/Hepatitis C is often known as a “silent killer” since many people who are infected do not realize they have the disease. With few symptoms associated with hepatitis C, they may be infected for decades without realizing it. Host Dr. Leslie Lundt welcomes Dr. Jorge Herrera to discuss who, why and whNarcolepsy
https://reachmd.com/programs/clinicians-roundtable/narcolepsy/1901/Is narcolepsy something that we really need to think about if we do not practice sleep medicine? The answer may surprise you. Narcolepsy expert Dr. Richard Bogan discusses the latest research with host Dr. Leslie Lundt.Autoimmune Lymphoproliferative Syndrome
https://reachmd.com/programs/clinicians-roundtable/autoimmune-lymphoproliferative-syndrome/1625/Dr. David Teachey, a practicing pediatric hematologist-oncologist, laboratory and clinical researcher, and instructor in the department of pediatrics, division of oncology, at the Children’s Hospital of Philadelphia, explains to host Bruce Bloom his breakthrough research that may resolve symptoms foTargeted Therapies in Cancer Research
https://reachmd.com/programs/clinicians-roundtable/targeted-therapies-in-cancer-research/1596/Dr. Steve Kron, Associate Professor, Molecular Genetics and Cell Biology at the University of Chicago, and a member of the Committees on Genetics, Cancer Biology, Cell Physiology, and Molecular Medicine discusses targeted therapies in cancer research.